论文部分内容阅读
The specific and robust effect of RNAi on gene expression renders siRNA a valuable therapeutic agent for the treatment of various diseases.However,the intrinsic deficiencies of siRNA,such as short plasma half-life,poor membrane penetrability and lack of target ability,have limited the development of its therapeutic application.To realize the therapeutic potential of siRNA,several strategies have been proposed to overcome the bottleneck for siRNA delivery in our laboratory.